Enbrel 25 MG/0.5 ML syringe 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26F6T0R
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,586
Award facts
- Contract value 100% obligated
- $12,585.95 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 24, 2025, for the supply of Enbrel 25 mg/0.5 mL syringes with a ceiling value of $12,585.95. This competitively awarded, firm fixed-price contract with no set-aside designation is scheduled for completion by November 25, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. Enbrel is a biologic immunosuppressant used to treat rheumatoid arthritis and other autoimmune conditions, and this delivery order represents a continuation of AmerisourceBergen's extensive pharmaceutical supply relationship with the Defense Logistics Agency's Medical Supply Chain.
This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a wide range of pharmaceutical products and medical supplies to military healthcare systems worldwide, including the Defense Health Agency and U.S. Coast Guard. AmerisourceBergen's position as a prime vendor reflects its demonstrated capability to meet federal procurement requirements for specialized medical commodities through open competition.
Quick answers
Who was awarded contract SPE2DR26F6T0R?
SPE2DR26F6T0R was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 24, 2025.
How much is contract SPE2DR26F6T0R worth?
The government has obligated $12,586 on SPE2DR26F6T0R.
Is contract SPE2DR26F6T0R an order under another contract?
Yes. SPE2DR26F6T0R is a delivery order under SPE2DR25D3013, an indefinite delivery contract.
Was contract SPE2DR26F6T0R competed?
The extent of competition for SPE2DR26F6T0R was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award